Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (390)	$ (1,427)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	665	839
Government and other legal settlements and related costs	8	10
Stock-based compensation expense	20	36
Impairment of hospitals sold or held for sale	6	1
Impairment and (gain) loss on sale of businesses, net	363	1,695
Loss from early extinguishment of debt	35	30
Gain on sale of investments in unconsolidated affiliates		(94)
Other non-cash expenses, net	24	19
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable	229	(40)
Supplies, prepaid expenses and other current assets	(37)	64
Accounts payable, accrued liabilities and income taxes	(215)	(256)
Other	(91)	(67)
Net cash provided by operating activities	617	810
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(4)	(122)
Purchases of property and equipment	(428)	(561)
Proceeds from disposition of hospitals and other ancillary operations	1,666	12
Proceeds from sale of property and equipment	4	10
Purchases of available-for-sale securities	(85)	(395)
Proceeds from sales of available-for-sale securities	133	386
Proceeds from sale of investments in unconsolidated affiliates		403
Distribution from Quorum Health Corporation		1,219
Increase in other investments	(95)	(201)
Net cash provided by investing activities	1,191	751
Cash flows from financing activities:
Repurchase of restricted stock shares for payroll tax withholding requirements	(5)	(5)
Deferred financing costs and other debt-related costs	(66)	(22)
Proceeds from noncontrolling investors in joint ventures	5
Redemption of noncontrolling investments in joint ventures	(5)	(19)
Distributions to noncontrolling investors in joint ventures	(79)	(69)
Borrowings under credit agreements	839	3,929
Issuance of long-term debt	3,100
Proceeds from receivables facility	26	66
Repayments of long-term indebtedness	(5,271)	(5,492)
Net cash used in financing activities	(1,456)	(1,612)
Net change in cash and cash equivalents	352	(51)
Cash and cash equivalents at beginning of period	238	184
Cash and cash equivalents at end of period	590	133
Supplemental disclosure of cash flow information:
Interest payments	(630)	(767)
Income tax payments, net of refunds	$ (5)	$ (6)